GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › BLLN growth analysis
Growth stock analysis · updated 2026-07-27

BillionToOne, Inc. Class A Common Stock (BLLN) growth stock analysis

Is BillionToOne, Inc. Class A Common Stock a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
49
Growth score
86
RS rating
#1,325
Rank
2/6
Traits passed
49/99
Growth score · 1325th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about BLLN

As of the 2026-07-27 close, BLLN scores 49 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 1325th of 4,897 rated US stocks, the top 27% of the market.

Its strongest trait is N (new highs & catalysts) at 72, and its weakest is S (supply & demand) at 43. BLLN clears 2 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, BLLN carries a strong Relative Strength rating of 86, meaning it has outperformed about 86% of the market over the past year.

Underneath the score: trading 3% below its 52-week high.

BLLN growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
A
Annual earnings growth
multi-year earnings trend
N
New highs & catalysts
proximity to new 52-week highs
72
S
Supply & demand
volume behind the move vs. share supply
43
L
Leader or laggard
Relative Strength within its group
69
I
Institutional sponsorship
fund accumulation and 13F ownership
59

Is BLLN a growth stock?

Not right now by CANSLIM

On today’s data BLLN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than BLLN

The stocks ranking above BLLN today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 BLLN price history & buy range

Where BLLN sits in its base, its 52-week path, and the trait trend over the past year.

Open the full BLLN profile →

See where BLLN ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

BLLN as a growth stock, frequently asked

Is BLLN a good growth stock?

Not right now by CANSLIM. On today’s data BLLN does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is BLLN's growth score?

BillionToOne, Inc. Class A Common Stock (BLLN) scores 49 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 1325th of 4,897 rated US stocks.

Does BLLN have strong earnings growth?

We don't have current earnings-growth figures for BLLN.

How strong is BLLN's price performance?

BLLN has a Relative Strength rating of 86, meaning it has outperformed roughly 86% of the US market over the trailing year.

Where can I see BLLN's full analysis?

Create a free Growth Stock Analyzer account to see where BLLN ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Services-Medical Laboratories